233 related articles for article (PubMed ID: 32319650)
21. Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
Salgia R
Cancer; 2011 Sep; 117(17):3889-99. PubMed ID: 21858799
[TBL] [Abstract][Full Text] [Related]
22. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
[TBL] [Abstract][Full Text] [Related]
23. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
Zhao WY; Wang Y; An ZJ; Shi CG; Zhu GA; Wang B; Lu MY; Pan CK; Chen P
Biochem Biophys Res Commun; 2013 Jun; 435(3):466-71. PubMed ID: 23673296
[TBL] [Abstract][Full Text] [Related]
26. Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model.
Jeong K; Yu YJ; You JY; Rhee WJ; Kim JA
Lab Chip; 2020 Feb; 20(3):548-557. PubMed ID: 31942592
[TBL] [Abstract][Full Text] [Related]
27. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
[TBL] [Abstract][Full Text] [Related]
29. miR‑140‑5p regulates cell migration and invasion of non‑small cell lung cancer cells through targeting VEGFA.
Yang P; Xiong J; Zuo L; Liu K; Zhang H
Mol Med Rep; 2018 Sep; 18(3):2866-2872. PubMed ID: 30015904
[TBL] [Abstract][Full Text] [Related]
30. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
Han L; Wang JN; Cao XQ; Sun CX; Du X
Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
[TBL] [Abstract][Full Text] [Related]
31. High Serum HDGF Levels Are Predictive of Bone Metastasis and Unfavorable Prognosis in Non-Small Cell Lung Cancer.
Zhang G; Liu Z; Chen Y; Zhang Y
Tohoku J Exp Med; 2017 Jun; 242(2):101-108. PubMed ID: 28592712
[TBL] [Abstract][Full Text] [Related]
32. MiR-646 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2.
Wang J; Shu H; Guo S
Cancer Med; 2020 Jun; 9(12):4360-4370. PubMed ID: 32347652
[TBL] [Abstract][Full Text] [Related]
33. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells.
Zhu YM; Azahri NS; Yu DC; Woll PJ
BMC Cancer; 2008 Jul; 8():218. PubMed ID: 18671849
[TBL] [Abstract][Full Text] [Related]
34. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.
Okuda Y; Nakamura H; Yoshida K; Enomoto H; Uyama H; Hirotani T; Funamoto M; Ito H; Everett AD; Hada T; Kawase I
Cancer Sci; 2003 Dec; 94(12):1034-41. PubMed ID: 14662017
[TBL] [Abstract][Full Text] [Related]
35. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A; Marchat LA; Sánchez LL; Romero-Zamora D; Arechaga-Ocampo E; Ramírez-Torres N; Chávez JD; Carlos-Reyes Á; Astudillo-de la Vega H; Ruiz-García E; González-Pérez A; López-Camarillo C
Proteomics Clin Appl; 2016 Feb; 10(2):172-82. PubMed ID: 26175166
[TBL] [Abstract][Full Text] [Related]
36. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
Wang M; Zhang J; Tong L; Ma X; Qiu X
Int J Clin Exp Pathol; 2015; 8(11):14110-20. PubMed ID: 26823724
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
Wang M; Wang W; Ding J; Wang J; Zhang J
Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
[TBL] [Abstract][Full Text] [Related]
38. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
[TBL] [Abstract][Full Text] [Related]
39. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
[TBL] [Abstract][Full Text] [Related]
40. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
